Evidence that the E2-isoprostane, 15-E(2t)-isoprostane (8-iso- prostaglandin E2) is formed in vivo

Journal of Lipid Research

Volumn 39, Issue 8, 1998, Pages 1589-1593

  Morrow, Jason D ^a   Scruggs, Jennifer ^a   Chen, Yan ^a   Zackert, William E ^a   Roberts II, L Jackson ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cicosanoid; Free radicals; Isoeicosanoids; Lipid peroxidation

Indexed keywords

ARACHIDONIC ACID; PROSTAGLANDIN E2 DERIVATIVE; 8 ISOPROSTAGLANDIN E2; 8-ISOPROSTAGLANDIN E2; DRUG DERIVATIVE; FREE RADICAL; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN E2;

ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; LIVER METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; ANIMAL; BIOSYNTHESIS; ISOLATION AND PURIFICATION; LIVER; MASS FRAGMENTOGRAPHY; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ARACHIDONIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINOPROSTONE; FREE RADICALS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; ISOPROSTANES; LIPID PEROXIDATION; LIVER; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031594968     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Halliwell, B., and J. M. C. Gutteridge. 1990. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186: 1-85.
2. Southorn, P. A., and G. Powis. 1988. Free radicals in medicine. II. Involvement in human disease. Mayo Clin. Proc. 63: 390-408.
3. Ames, B. N. 1983. Dietary carcinogens and anticarcinogens. Science. 221: 1256-1264.
4. Harman, D. 1983. The aging process. Proc. Natl. Acad. Sci. USA. 78: 7124-7128.
5. Pryor, W. A., J. P. Stanley, and E. Blair. 1976. Autoxidation of polyunsaturated fatty acids. II. A suggested mechanism for the formation of TBA-reactive materials form prostaglandin-like endoperoxides. Lipids. 11: 370-379.
6. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA. 87: 9383-9387.
7. Morrow, J. D., T. M. Harris, and L. J. Roberts. 1990. Non-cyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for the measurement of eicosanoids. Anal. Biochem. 184: 1-10.
8. 2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA. 89: 10721-10725.
9. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. J. Clin. Invest. 90: 2502-2507.
10. Morrow, J. D., and L. J. Roberts. 1997. The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid. Res. 36: 1-21.
11. 2α is formed in vivo. Biochim. Biophys. Acta. 1210: 244-248.
12. Morrow, J. D., T. A. Minton, C. R. Mukundan, M. D. Campbell, W. E. Zackert, V. C. Daniel, K. F. Badr, I. A. Blair, and L. J. Roberts. 1994. Free radical-induced generation of isoprostanes in vivo: evidence for the formation of D-ring and E-ring isoprostanes. J. Biol. Chem. 269: 4317-4326.
13. 2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. Prostaglandins. 48: 247-256.
14. 2-isoprostane. Biochem. Biophys. Res. Comm. 195: 507-515.
15. Daniels, E. G., W. C. Krueger, F. P. Kupiecki, J. E. Pike, and W. P. Schneider. 1968. Isolation and characterization of a new prostaglandin isomer. J. Am. Chem. Soc. 90: 5894-5895.
16. Radin, N. S. 1969. Preparation of lipid extracts. Methods Enzymol. 14: 245-248.
17. Hughes, H., C. V. Smith, E. C. Horning, and J. R. Mitchell. 1983. High-performance liquid chromatography and gas chromatography-mass spectrometry determination of specific lipid peroxidation products in vivo. Anal. Biochem. 130: 431-436.
18. 2-Isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. 1994. Methods Enzymol. 233: 163-174.